COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14231441

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a mTOR inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a mTOR inhibitor such as Temsirolimus or Everolimus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROCHE GLYCART AGWAGISTRASSE 18 SCHLIEREN 8952

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HERTING, FRANK PENZBERG, DE 47 209
KLEIN, CHRISTIAN BONSTETTEN, CH 571 9941

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation